Through the process of discovery and innovation, the evolution of clinical practice affords clinicians the opportunity to gain new skills and improve decision making as a result of new, high-fidelity patient data collected and enhanced workflow these opportunities create. Today, however, we have seen a glut of emerging technologies, diagnostics, and equipment create confusion in […]
Read articleJune 6, 2018—Palo Alto, CA—SyncThink, a leader in neurotechnology and brain health analytics with foundational IP in eye tracking, had its EYE-SYNC technology named by MedTech Breakthrough as the best new technology solution for monitoring in its 2018 MedTech Breakthrough Awards program. The EYE-SYNC technology is an eye tracking solution currently used by top organizations […]
Read articleAn FDA clearance is necessary to market a medical device in the United States. Everyone is aware that regulatory hurdles can be an expensive, intrusive process. Having one carries a lot of weight. However, few companies have been through the process and rarely discuss the challenges. But there are benefits to transparency. Users of SyncThink […]
Read articleWhen Opportunity Knocks When I was first exposed to the EYE-SYNC technology, I had already been working for five years as part of a collaborative, multidisciplinary group of researchers at Stanford to better understand the natural history of head injury. We maintained a collective curiosity about novel ways this epidemic could be better understood, […]
Read articleI have had the good fortune to enjoy over 25 years of building a range of software businesses – enterprise and consumer – big companies and startups. I loved the challenge and am proud of the positive impact of these products which have touched millions (SugarSync, Catch) and in some cases hundreds of millions (Netscape, […]
Read articleSyncThink, a world leader in neurotechnology and brain health analytics with foundational IP in eye-tracking, announces the appointment of Laura Yecies as its new CEO.
Read articleBy Jon Swartz March 16, 2018 4:03 p.m. ET Richard Sherman plays football for a living, but he’s also tackling the technology game. The four-time Pro Bowl cornerback, who recently signed a three-year, $39.15 million free-agent contract with the San Francisco 49ers, is one of a growing number of NFL stars helping promote tech start-ups. He’s an […]
Read articleVirtual reality in medicine is certainly a hot trend at the moment, with the global market for VR in healthcare expected to reach 3.8 billion by 2020. Justin Barad, Founder and CEO of startup Osso VR, summarizes the impact of immersive technology in medicine: “Virtual Reality is a unique technology that has a wide variety of disruptive medical […]
Read articlePalo Alto, CA—January 3, 2018—Sync-Think, Inc. (“SyncThink” and the “Company”) a world leader in neuro-technology and proprietary eye-tracking intellectual property, announces the closing of a Series A-1 Preferred Stock funding round consisting of $3.5 million dollars in cash subscriptions, led by Quadrant Management, Inc. The Company expects to utilize the proceeds from the offering to […]
Read articleSyncThink was granted another huge patent that captures eye tracking attention and analyzes for a variety of purposes. SyncThink, a leader in neurotechnology and creator of EYE-SYNC, announces today the granting of patent US 14/530,598 by the U.S. Patent and Trade Office. This patent allows SyncThink to use system and methods for creating and changing […]
Read articleA world leader in neuro-technology with foundational in IP in eye-tracking, SyncThink, adds New Orleans’ Saints Tight End, Coby Fleener, to its Athlete Advisory Board. In this advisory capacity, Fleener will contribute to the continued SyncThink mission of providing an objective solution with the SyncThink Platform. EYE-SYNC is designed with VR and eye-tracking technology to […]
Read article